OICR News / Tag

Immuno-oncology

TAG ARCHIVE

Browse news tagged Immuno-oncology.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

TalentBreast cancer

New OICR President and Scientific Director comments on breakthrough in breast cancer T-cell immunotherapy

For the first time, a patient’s late-stage breast cancer has been successfully treated with T-cell immunotherapy. This cutting-edge approach, which is currently in clinical trials in the U.S., modified the patient’s naturally-occurring immune cells to…

ArticleJun 14, 2018

TechnologyStomach cancer

Viral protein identified as one of the main drivers of virus-induced stomach cancers

Some common pathogens, like the Epstein-Barr virus (EBV), can turn healthy cells into cancer cells, but it is not well understood how they do so. Better understanding how such pathogens work allows researchers to find…

ArticleJun 13, 2018

TechnologyTreatment

Combination of erectile dysfunction drugs and flu vaccine may help kill remaining cancer after surgery

A remarkable study led by Dr. Rebecca Auer from The Ottawa Hospital (TOH) shows that the unlikely combination of erectile dysfunction drugs and the flu vaccine may boost the immune system’s ability to clean up…

ArticleMay 17, 2018

TechnologyBreast cancer

Scientists create method to sensitize triple-negative breast cancer to common immunotherapy

Immunotherapy, which boosts the body’s immune system to kill cancer cells, has shown remarkable promise in treating many types of cancer. Now researchers have found a way to use immunotherapy against triple-negative breast cancer (TNBC),…

ArticleJan 19, 2018

TechnologyBreast cancer

Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer

Researchers at The Ottawa Hospital and the University of Ottawa have found that a combination of two immunotherapies – oncolytic viruses and checkpoint inhibitors – was successful in treating triple-negative breast cancer in mouse models.…

ArticleJan 04, 2018

CommercializationTreatment

Ontario start-up makes major deal to develop cancer-fighting viruses

Partners congratulate Turnstone Biologics Canadian academic institutions and research organizations are congratulating Turnstone Biologics on a new partnership with AbbVie to develop cancer-fighting viruses (also called oncolytic viral immunotherapies). Turnstone was founded in Ottawa based…

ArticleOct 11, 2017

← Previous Next stories →

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.